VANECK BIONIC ENGINEERING UCITS ETF - USD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.25 USD | +0.14% |
|
+0.85% | +1.66% |
| Current month | -4.56% | ||
| 1 month | -1.77% |
Investment objective
VanEck?s Bionic Engineering ETF tracks the performance of the portfolio of innovative companies delivering medical, dental or vision-related implants, bioprinting, prosthesis, or preservation of organs and tissue.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 323.8 AUD | +0.95% | +0.24% | +8.42% | -.--% | ||
| 258.2 CHF | +0.49% | +1.93% | -5.90% | -.--% | ||
| 138.9 CHF | +0.60% | +2.78% | +2.40% | -.--% | ||
| 338.5 DKK | +3.64% | +5.82% | +14.32% | -.--% | ||
| 79.74 USD | +0.62% | +0.33% | -3.20% | -.--% | ||
| 31.61 EUR | +0.32% | +0.13% | +0.86% | -.--% | ||
| 129,900 KRW | -0.08% | -2.62% | -0.84% | -.--% | ||
| 1.69 HKD | +0.60% | +5.62% | -28.09% | -.--% | ||
| 6.27 HKD | +6.27% | +16.11% | -25.53% | -.--% | ||
| 12.44 USD | +1.63% | -0.80% | -17.67% | -.--% | ||
More news
In partnership with
| Date | Price | Change |
|---|---|---|
| 26/04/24 | 21.25 | +0.14% |
| 25/04/24 | 21.22 | -1.83% |
| 24/04/24 | 21.61 | +0.52% |
| 23/04/24 | 21.5 | +1.84% |
| 22/04/24 | 21.11 | +0.21% |
Other stock markets
Delayed Quote London S.E.
Last update April 26, 2024 at 04:35 pm
More quotesDescription
| IE0005TF96I9 | |
|---|---|
| Total Expense Ratio | 0.55% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | MVIS Global Bionic Healthcare ESG Index (NTR) - USD |
Features and characteristics
| Jurisdiction | |
| Replication Method | |
| Replication Model | |
| Date of creation |
01/12/2022
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 27/03/2024 )
| AuM (EUR) | 6 M€ |
|---|---|
| AuM 1M | 6 M€ |
| AuM 3 months | 5 M€ |
| AuM 6 months | 5 M€ |
| AuM 12 months | 5 M€ |
- Stock Market
- ETF
- ETF
